InsiderClue
Insiders · Profile

Degnan Chris

Chief Financial Officer at UroGen Pharma · Chief Financial Officer at Verrica Pharmaceuticals. Filing since 19 Jun 2018. CIK 0001741968

URGN UroGen Pharma Ltd. Chief Financial Officer · 2 trades VRCA Verrica Pharmaceuticals Inc. Chief Financial Officer · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
URGN UroGen Pharma Ltd.
8 Oct 2026
Chief Financial Officer
Sold at will
2,202
$80.79K
32.6%
URGN UroGen Pharma Ltd.
8 Oct 2025
Chief Financial Officer
Sold at will
2,203
$37.12K
49.1%
VRCA Verrica Pharmaceuticals Inc.
19 Jun 2018
Chief Financial Officer
Bought
3,000
$45.00K
opened
3 decisions on file.